The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of surufatinib in United States (US) patients (pts) with neuroendocrine tumors (NETs).
 
Arvind Dasari
Consulting or Advisory Role - Abbvie/Stemcentrx; Ipsen; Lexicon; Novartis; Voluntis
Research Funding - eFFECTOR Therapeutics; Eisai; Guardant Health; Hutchison MediPharma; Merck; Novartis
 
Daneng Li
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Genentech; Ipsen; Lexicon; Taiho Pharmaceutical
Speakers' Bureau - Advanced Accelerator Applications; Eisai; Exelixis; Ipsen; Lexicon
Research Funding - Brooklyn ImmunoTherapeutics (Inst)
 
Max W. Sung
Consulting or Advisory Role - Bayer; Eisai; Exelixis
 
Christopher Tucci
Employment - Hutchison MediPharma
 
John S. Kauh
Employment - Glenmark; Hutchison MediPharma; Lilly
Stock and Other Ownership Interests - Hutchison MediPharma; Lilly
Travel, Accommodations, Expenses - Glenmark; Hutchison MediPharma; Lilly
 
Marek K. Kania
Employment - Hutchison MediPharma
Leadership - Hutchison MediPharma
Stock and Other Ownership Interests - Hutchison MediPharma; Lilly
 
Andrew Scott Paulson
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Immunomedics
Honoraria - Cardinal Health
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bristol-Myers Squibb; Eisai; Ipsen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Hutchison MediPharma (Inst); incyte (Inst); Ipsen (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen